Tech Company Financing Transactions
Blue Ash Therapeutics Funding Round
On 6/30/2010, Blue Ash Therapeutics received $2 million in financing from CincyTech and private investors.
Transaction Overview
Company Name
Announced On
6/30/2010
Transaction Type
Venture Equity
Amount
$2,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
100 East 4th St. 1400
Cincinnati, OH 45202
USA
Cincinnati, OH 45202
USA
Phone
Website
Email Address
Not Recorded
Overview
Blue Ash Therapeutics, LLC was formed in December 2008 in Cincinnati to bring a promising cardiovascular drug -- azimilide - to market.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Gregory Flexter
Chief Operating Officer
Kevin Malloy
Browse more venture capital transactions:
Prev: 6/30/2010: Dicerna Pharmaceuticals venture capital transaction
Next: 6/30/2010: Tabula Digita venture capital transaction
Share this article
News on VC Transactions
We document tech company VC transactions. VC investment data records reported here come from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs